Colston K W, Evans I M, Spelsberg T C, MacIntyre I
Biochem J. 1977 Apr 15;164(1):83-9. doi: 10.1042/bj1640083.
Many factors influence the production of 1,25(OH)2D3 (1,25-dihydroxycholecalciferol) by the kidney. One important factor seems to be feedback regulation by 1,25(OH)2D3 itself. Administration of 1,25(OH)2D3 to vitamin D-deficient chicks abolishes renal 25(OH)D3(25-hydroxycholecalciferol)1-hydroxylase activity and induces the appearance of 25(OH)D3 24-hydroxylase activity. It is likely that these effects are mediated via a nuclear effect, as they are prevented by pretreatment with actinomycin D and alpha-amanitin. Further, 1,25(OH)2D3 has a marked effect on gene transcription in the kidney cell, as assessed by measurement of RNA polymerase activities. RNA polymerase I and II activities are 80-90% inhibited by 12.5nmol of 1,25(OH)2D3 within 30min of subcutaneous administration, indicating an immediate and massive decrease in total gene transcription. By 4h RNA polymerase II activity has returned to control values, but RNA polymerase I activity is markedly enhanced. These results are consistent with the view that regulation of cholecalciferol metabolism in the kidney is associated with an effect of the active metabolite on the kidney nucleus.
许多因素影响肾脏生成1,25(OH)₂D₃(1,25 - 二羟胆钙化醇)。一个重要因素似乎是1,25(OH)₂D₃自身的反馈调节。给维生素D缺乏的雏鸡注射1,25(OH)₂D₃可消除肾脏25(OH)D₃(25 - 羟胆钙化醇)1 - 羟化酶活性,并诱导25(OH)D₃ 24 - 羟化酶活性出现。这些效应可能是通过核效应介导的,因为用放线菌素D和α - 鹅膏蕈碱预处理可阻止这些效应。此外,通过测量RNA聚合酶活性评估,1,25(OH)₂D₃对肾细胞中的基因转录有显著影响。皮下注射12.5nmol的1,25(OH)₂D₃后30分钟内,RNA聚合酶I和II的活性被抑制80 - 90%,表明总基因转录立即大幅下降。到4小时时,RNA聚合酶II的活性恢复到对照值,但RNA聚合酶I的活性显著增强。这些结果与以下观点一致,即肾脏中胆钙化醇代谢的调节与活性代谢产物对肾细胞核的作用有关。